Table 1 Example of anti-cancer drugs phase I/II completed studies

Colorectal cancer

Drug: Capecitabine and Aflibercept

Metastatic breast cancer

Drug: Tivozanib (AV-951) + paclitaxel

Bladder cancer

Biological: Vesigenurtaclel-1 (HS-410)

Biological: Placebo

Biological: BCG

Ovarian cancer

Primary peritoneal

Drug: Pemetrexed—Phase 1

Drug: Carboplatin—Phase 1

Drug: Pemetrexed—Phase 2

Drug: Carboplatin—Phase 2

Non-small cell lung cancer

Drug: Pazopanib

Drug: Paclitaxel

Non small lung cancer

Drug: Pemetrexed

Drug: Cisplatin

Drug: Rabusertib (LY2603618)

Pancreatic cancer

Drug: Vantictumab (OMP-18RS)

Drug: Nab-paclitaxel

Drug: Gemcitabine